This is the authors' abstract. We don't add key points for this paper.
New technologies in dermoscopy are often judged by whether they outperform clinicians on selected images. This Editorial argues that a meaningful advance should instead improve care in real clinical settings. Evidence from artificial intelligence, reflectance confocal microscopy, site-specific dermoscopy, and teledermoscopy suggests that the greatest gains occur when technology is integrated with trained clinical judgment, validated prospectively, tested across skin types and anatomical sites, and evaluated for access and patient-relevant outcomes. The central question is not whether a person or machine performs better alone, but whether the combination helps identify skin cancer earlier while avoiding unnecessary biopsies.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pham et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: